Blog

COVID-19 Monoclonal Antibodies and Effectiveness Against Variants
The Centers for Disease Control and Prevention (CDC) report that the COVID-19 variant first identified in the U.K.—B.1.1.7—is the most common cause of new infection
April 23, 2021

Messenger RNA Vaccines Against COVID-19 and its Variants
The novel messenger RNA (mRNA) vaccines developed by Pfizer-BioNTech (BNT162b2) and Moderna (mRNA-1273) carry the genetic code the host cell needs to make the surface
April 9, 2021

Coronavirus Variants and their Impact on Treatment
New coronavirus variants are circulating in the United States. The Department of Health and Human Services (HHS) established a SARS-CoV-2 interagency group (SIG) to improve
March 10, 2021